title: Estrogens regulate angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary.
abstract: We studied the effects of the estrous cycle, ovariectomy and estrogen replacement on angiotensin-converting enzyme (ACE) (kininase II, EC 3.4.15.1) and angiotensin II (AT) receptors in the pituitary gland of the female rat. Quantitative autoradiography, with the use of consecutive pituitary sections, allowed for simultaneous determination of changes in binding and in the potential AT synthetic ability of individual pituitaries, and for a correlation between these two phenomena. In the anterior pituitary, ACE activity and binding of the ACE inhibitor [125I]-351A were not changed during the estrous cycle. Ovariectomy produced a significant increase in ACE activity and binding, and both of these parameters returned to normal after estrogen replacement. There were no changes in ACE activity or binding in the posterior pituitary during the estrous cycle or after ovariectomy or hormone replacement. AT receptors were characterized as of the AT1 type, since they were displaced by the selective AT1 antagonist DuP 753 and not by the AT2 competitor PD 123177. There were marked changes in the concentration of AT1 receptors during the estrous cycle, with highest numbers in metestrus, lower in estrus and diestrus, and lowest during proestrus. Estrogen replacement in ovariectomized rats decreased AT1 receptor number in the anterior pituitary. Our results indicate a dual effect of estrogen on anterior pituitary AT, physiologically on AT receptor expression and pharmacologically on ACE activity.
authors.affiliation: Section on Pharmacology, National Institute of Mental Health, Bethesda, Md. 20892.
authors.forename: A
authors.initials: A
authors.lastname: Seltzer
authors.forename: J E
authors.initials: JE
authors.lastname: Pinto
authors.forename: P N
authors.initials: PN
authors.lastname: Viglione
authors.forename: F M
authors.initials: FM
authors.lastname: Correa
authors.forename: C
authors.initials: C
authors.lastname: Libertun
authors.forename: K
authors.initials: K
authors.lastname: Tsutsumi
authors.forename: M K
authors.initials: MK
authors.lastname: Steele
authors.forename: J M
authors.initials: JM
authors.lastname: Saavedra
mesh_terms: D000804:Angiotensin II / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000378:metabolism; D000818:Animals; D001345:Autoradiography; D004031:Diestrus / Q000502:physiology; D004151:Dipeptides / Q000378:metabolism; D004967:Estrogens / Q000494:pharmacology*; D004971:Estrus / Q000502:physiology; D005260:Female; D010052:Ovariectomy; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism*; D011359:Proestrus / Q000502:physiology; D011506:Proteins / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D011945:Receptors, Angiotensin / Q000378:metabolism*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004151:Dipeptides; D004967:Estrogens; D011506:Proteins; D011945:Receptors, Angiotensin; C042037:L-proline, N2-((1S)-1-carboxy-3-phenylpropyl)-N6-((4-hydroxyphenyl)iminomethyl)-L-lysyl-; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A